Keros Therapeutics, Inc. (KROS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jasbir Seehra
Employees:
23
99 HAYDEN AVENUE, SUITE 120 (BLD E), LEDGEMONT TECHNOLOGY CENTER, LEXINGTON, MA 02421
617-513-8774

Keros Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. Keros Therapeutics serves customers in worldwide. Our principal executive office is located at 99 Hayden Avenue, Suite 120, Building E, Lexington, Massachusetts 02421. Our telephone number is (617) 314-6297. Our website address is www.kerostx.com.

Data derived from most recent annual or quarterly report
Market Cap 942.383 Million Shares Outstanding23.338 Million Avg 30-day Volume 153.452 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 88.8 / 28.5 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from KROS instead.

View recent insider trading info

Funds Holding KROS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KROS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

143 Thousand total shares from 32 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KNOWLES JULIUS

  • Director
717,254 2021-10-19 15

LACHEY JENNIFER CHIEF SCIENTIFIC OFFICER

  • Officer
85,700 2021-08-17 10

COOPER SIMON PETER CHIEF MEDICAL OFFICER

  • Officer
60,000 2021-08-10 2

ORDONEZ CLAUDIA CHIEF MEDICAL OFFICER

  • Officer
98,211 2021-06-11 6

GRAY MARY ANN

  • Director
8,293 2021-06-01 3

GORDON CARL L

  • Director
8,293 2021-06-01 1

KARIV TOMER

  • Director
  • 10% Owner
8,293 2021-06-01 1

NUSSBAUM RAN

  • Director
  • 10% Owner
8,293 2021-06-01 1

FARZAN NIMA

  • Director
8,293 2021-06-01 1

REGNANTE KEITH CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-10 1

SEEHRA JASBIR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-10 1

KARIV TOMER

PONTIFAX (ISRAEL) IV, L.P.

PONTIFAX (CAYMAN) IV L.P.

PONTIFAX (CHINA) IV L.P.

PONTIFAX LATE STAGE FUND L.P.

PONTIFAX LATE STAGE GP LTD.

  • Director
  • 10% Owner
4,794,507 2020-11-17 3

NUSSBAUM RAN

PONTIFAX (ISRAEL) IV, L.P.

PONTIFAX (CAYMAN) IV L.P.

PONTIFAX (CHINA) IV L.P.

PONTIFAX LATE STAGE FUND L.P.

PONTIFAX LATE STAGE GP LTD.

  • Director
  • 10% Owner
4,794,507 2020-11-17 3

PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.

PONTIFAX (ISRAEL) IV, L.P.

PONTIFAX (CAYMAN) IV L.P.

PONTIFAX (CHINA) IV L.P.

PONTIFAX LATE STAGE FUND L.P.

PONTIFAX LATE STAGE GP LTD.

  • 10% Owner
4,794,507 2020-11-17 3

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VII LLC

ORBIMED GENESIS GP LLC

  • Director
2,013,346 2020-04-13 0

ARKIN BIO VENTURES LIMITED PARTNERSHIP

ARKIN BIO VENTURE PARTNERS LTD.

ARKIN MOSHE

  • 10% Owner
2,013,102 2020-04-13 0

LAZARUS ALON

  • Director
  • 10% Owner
2,036,140 2020-04-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-20 S 148 $37.55 d 290,619 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-20 S 1,463 $38.31 d 289,156 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-20 S 229 $37.55 d 430,340 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-20 S 2,242 $38.31 d 428,098 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-19 S 704 $38.49 d 430,569 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-19 S 1,323 $38.05 d 291,227 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-19 S 460 $38.49 d 290,767 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-21 16:29:15 -0400 2021-10-19 S 2,029 $38.05 d 431,273 indirect yes 4.0185 4.0185 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-18 S 60 $38.46 d 292,550 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-18 S 8,252 $37.69 d 433,394 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-18 S 92 $38.46 d 433,302 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-18 S 5,382 $37.69 d 292,610 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-15 S 1,199 $39.44 d 298,052 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-15 S 3,031 $38.95 d 443,577 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-15 S 60 $40.60 d 297,992 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-15 S 1,839 $39.44 d 441,738 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-15 S 92 $40.60 d 441,646 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-15 S 1,977 $38.95 d 299,251 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-14 S 1,730 $40.13 d 301,228 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-18 20:35:55 -0400 2021-10-14 S 2,653 $40.13 d 446,608 indirect yes 0.105 0.105 2 0.0 1

KNOWLES JULIUS - Director see footnote

2021-10-05 20:47:33 -0400 2021-10-05 S 1,033 $40.03 d 302,958 indirect yes 0.4588 3.1309 4.5884 5 -0.2699 3

KNOWLES JULIUS - Director see footnote

2021-10-05 20:47:33 -0400 2021-10-05 S 1,584 $40.03 d 449,261 indirect yes 0.4588 3.1309 4.5884 5 -0.2699 3

KNOWLES JULIUS - Director see footnote

2021-10-05 20:47:33 -0400 2021-10-04 S 2,267 $40.06 d 450,845 indirect yes 0.4588 3.1309 4.5884 5 -0.2699 3

KNOWLES JULIUS - Director see footnote

2021-10-05 20:47:33 -0400 2021-10-04 S 1,479 $40.06 d 303,991 indirect yes 0.4588 3.1309 4.5884 5 -0.2699 3

KNOWLES JULIUS - Director see footnote

2021-10-05 20:47:33 -0400 2021-10-01 S 2,496 $40.16 d 305,470 indirect yes 0.4588 3.1309 4.5884 5 -0.2699 3

KNOWLES JULIUS - Director see footnote

2021-10-05 20:47:33 -0400 2021-10-01 S 3,827 $40.16 d 453,112 indirect yes 0.4588 3.1309 4.5884 5 -0.2699 3

KNOWLES JULIUS - Director see footnote

2021-09-29 16:39:15 -0400 2021-09-27 S 27,373 $40.51 d 487,249 indirect yes 0.8847 -5.9151 0.8847 2 -6.3448 5

KNOWLES JULIUS - Director see footnote

2021-09-29 16:39:15 -0400 2021-09-27 S 6,532 $42.29 d 307,966 indirect yes 0.8847 -5.9151 0.8847 2 -6.3448 5

KNOWLES JULIUS - Director see footnote

2021-09-29 16:39:15 -0400 2021-09-27 S 20,292 $41.52 d 466,957 indirect yes 0.8847 -5.9151 0.8847 2 -6.3448 5

KNOWLES JULIUS - Director see footnote

2021-09-29 16:39:15 -0400 2021-09-27 S 10,018 $42.29 d 456,939 indirect yes 0.8847 -5.9151 0.8847 2 -6.3448 5

KNOWLES JULIUS - Director see footnote

2021-09-29 16:39:15 -0400 2021-09-27 S 17,854 $40.51 d 327,731 indirect yes 0.8847 -5.9151 0.8847 2 -6.3448 5

KNOWLES JULIUS - Director see footnote

2021-09-29 16:39:15 -0400 2021-09-27 S 13,233 $41.52 d 314,498 indirect yes 0.8847 -5.9151 0.8847 2 -6.3448 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KEROS THERAPEUTICS INC KROS 2021-10-26 22:15:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 21:45:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 21:15:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 20:45:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 20:15:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 19:45:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 19:15:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 18:45:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 18:15:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 17:45:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 17:15:03 UTC -0.4301 0.5001 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 16:45:04 UTC -0.4937 0.5637 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 16:15:03 UTC -0.4937 0.5637 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 15:45:03 UTC -0.4937 0.5637 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 15:15:03 UTC -0.4937 0.5637 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 14:45:03 UTC -1.7791 1.8491 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 14:15:05 UTC -1.7791 1.8491 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 13:45:03 UTC -1.7791 1.8491 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 13:15:03 UTC -1.7791 1.8491 30000
KEROS THERAPEUTICS INC KROS 2021-10-26 12:45:03 UTC -1.7791 1.8491 30000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments